Abbott may issue $3bn of notes

Abbott Laboratories, maker of the arthritis drug Humira, may issue $3 billion of notes in the biggest US corporate bond sale in a month.

The offering comprises $750 million of five-year notes that may yield 70 basis points more than similar-maturity Treasuries, $1 billion of 10-year debt that may pay 90 basis points more than governments and $1.25 billion of 30-year bonds that may pay a 122-basis-point spread. – (Bloomberg)